Search

Your search keyword '"Cave J."' showing total 337 results

Search Constraints

Start Over You searched for: Author "Cave J." Remove constraint Author: "Cave J."
337 results on '"Cave J."'

Search Results

1. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

3. Body composition and lung cancer-associated cachexia in TRACERx

4. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

5. Genomic–transcriptomic evolution in lung cancer and metastasis

6. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

7. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

8. The evolution of lung cancer and impact of subclonal selection in TRACERx

10. MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J

13. The evolution of lung cancer and impact of subclonal selection in TRACERx

15. The Australian 2019/2020 Black Summer Bushfires: Analysis of the Pathology, Treatment Strategies and Decision Making About Burnt Livestock

17. Standardising definitions for the pre-eclampsia core outcome set: A consensus development study

19. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

23. A core outcome set for pre-eclampsia research: an international consensus development study

24. Bank branch deposit competitiveness and deposit growth: Granular data and a new measure of competitiveness

25. Successful transcatheter pulmonary valve implantation in a dog: first clinical report

27. The influence of heating temperature on the superconducting properties of silver-gold sheathed Bi-2223 tapes destined for power applications

28. Development of inductive fault current limiters up to 100kVA class using bulk HTS materials

31. Introduction to section E1

32. Recent advances in the molecular landscape of lung neuroendocrine tumors

34. PL02.09 National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC)

37. Relationship between body mass index (BMI), body composition and outcomes in patients receiving first line chemotherapy for advanced or metastatic non-small cell lung cancer (NSCLC): a single centre experience

40. Timely Digital Patient-Clinician Communication in Specialist Clinical Services for Young People:A Mixed-Methods Study (The LYNC Study)

44. Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer

45. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

49. Putting the IC into ‘Policy’: strategic analysis for optimising the role of ICT in EU policy delivery

50. Mapping smart cities in the EU

Catalog

Books, media, physical & digital resources